Skip to main content
. 2021 Oct 29;13:754123. doi: 10.3389/fnagi.2021.754123

FIGURE 9.

FIGURE 9

Post-treatment with gliquidone reduces LPS-stimulated IL-1β and IL-6 mRNA levels in primary astrocytes. (A,B) Real time-PCR (q-PCR) analysis of SUR1 mRNA levels in primary astrocytes treated sequentially with LPS and gliquidone as indicated (6 h, n = 8/group; 24 h, n = 6/group). (C–F) Real time-PCR (q-PCR) analysis of proinflammatory cytokine levels in primary astrocytes treated sequentially with LPS and gliquidone as indicated (n = 8/group). **p < 0.01, ***p < 0.001.